Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jun;62(6):475-82.
doi: 10.1136/thx.2006.066670. Epub 2007 Jan 18.

Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma

Yusheng Qiu  1 , Jie Zhu, Venkata Bandi, Kay K Guntupalli, Peter K Jeffery
Affiliations

Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma

Yusheng Qiu et al. Thorax. 2007 Jun.

Abstract

Background: A study was undertaken to test the hypothesis that severe exacerbations of asthma are characterised by increased bronchial mucosal neutrophilia associated with upregulation of neutrophil chemoattractant ligands and their specific cell surface receptors.

Methods: Immunohistology and in situ hybridisation were applied to endobronchial biopsy specimens from three groups: (1) 15 patients admitted to hospital with a severe exacerbation of asthma (E-asthma), (2) 15 with stable asthma (S-asthma) and (3) 15 non-atopic and non-smoker surgical controls (NSC).

Results: There were significantly more neutrophils and eosinophils in the epithelium and subepithelium of patients in the E-asthma group (median (range) neutrophils 7 (0-380) and 78 (10-898)/mm2, eosinophils 31 (0-167) and 60 (6-351)/mm2, p<or=0.01 compared with NSC: 0 (0-10, 0-7, 0-18 and 0-3)/mm2, respectively), resulting in similar final densities of eosinophils and neutrophils. With respect to neutrophil chemoattractants and receptors, counts of CXCL5, CXCL8, CXCR1 and CXCR2 mRNA-positive cells in the subepithelium of the E-asthma group were, respectively, 5, 4, 4 and 18 times greater (p<or=0.01) than those of the NSC group. In the E-asthma group, cells expressing CXCL5 or CXCR2 were eightfold and threefold more frequent than those expressing CXCL8 or CXCR1 mRNA, respectively (p<0.01). CXCL5 and CXCR2 in E-asthma were associated with the number of eosinophils (r=0.59 and 0.66, p<0.02 for both) rather than the number of neutrophils.

Conclusion: In severe exacerbations of asthma there is a bronchial mucosal neutrophilia, eosinophilia and upregulation of CXC chemoattractants and their receptors. CXCL5 and CXCR2 have an association with eosinophila only, and these represent potentially new targets for treatment in exacerbations of asthma.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None.

Comment in

References

    1. Cochrane G M, Jackson W F, Rees P J. Epidemiology of asthma. In: Cochrane GM, Jackson WF, Rees PJ, eds. Asthma: current perspectives London: Mosby‐Wolfe, 20015–16.
    1. Jeffery P K. Immunopathology: comparison of COPD and asthma. In: Hansel TT, Barnes PJ, eds. New drugs for asthma, allergy and COPD. Basel: Karger, 200124–29.
    1. Barnes P J. Mechanisms in COPD: differences from asthma. Chest 200011710–4S. - PubMed
    1. Jeffery P K. Comparison of the structural and inflammatory features of COPD and asthma. Chest 2000117251–60s. - PubMed
    1. Fahy J V, Kim K W, Liu J.et al Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 199595843–852. - PubMed

Publication types

MeSH terms

Substances